Behavioural Health, Development and Pharma Production

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Behavioural Health

Development

Pharma Production

SparkRx: The first digital therapeutic for adolescents

pharmaphorum

MAY 9, 2022

SparkRx is designed to decrease depression in individuals aged 13 to 22 by providing a multi-week programme based on cognitive behavioural therapy (CBT) and behavioural activation protocols. “In In primary care, there are guidelines to screening for behavioural health concerns like depression annually. Designing the app.

Behavioural Health

Behavioural Health Production Life Science Development

Orexo eyes opioid use disorder app launch before year-end

pharmaphorum

OCTOBER 2, 2020

“Modia is designed to close the gap as it relates to the access and receipt of quality, evidence-based therapeutic interventions and behavioural health services for individuals with OUD who participate in outpatient treatment with MAT,” said Michael Sumner, Orexo’s chief medical officer.

Behavioural Health

Behavioural Health Production FDA Approval Pharma Production

Clinical Research Informer

SparkRx: The first digital therapeutic for adolescents

Orexo eyes opioid use disorder app launch before year-end

Stay Connected